We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Sunrest Lifescience Ltd. is an India-based pharmaceutical company primarily engaged in the marketing and distribution of a diverse range of healthcare and personal care products within the domestic market. The company operates on an asset-light business model, outsourcing manufacturing to third-party producers and focusing its core competencies on product selection, marketing, and distribution. Its extensive product portfolio includes both over-the-counter (OTC) and prescription-based pharmaceutical formulations, encompassing tablets, capsules, ointments, injectables, syrups, and various other forms. Sunrest Lifescience caters to numerous therapeutic segments, including anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, analgesic, nutritional, ayurvedic, and cosmetic products. The company primarily targets consumers in India, with significant market presence and a network of distributors and retailers across states such as Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, and Orissa.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save SUNREST.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
